World Health Organization

WHO convenes global consultation to intensify action to end TB in children and adolescents

29 November 2019 | Hanoi: The pace of progress in addressing TB in children and adolescents remains slow, especially in ensuring access to TB prevention and care. To address this critical issue, WHO convened a global consultation on 26-28 November in Hanoi, Viet Nam, bringing together over 100 stakeholders from across 12 countries including national TB programmes, paediatric societies, technical and financial partners as well as civil society. The consultation was hosted by the Viet Nam Government.

Read More →

2nd anniversary of the WHO Global Ministerial Conference on Ending TB

To mark the 2nd anniversary of the first-ever WHO Global Ministerial Conference on Ending TB in Moscow, the World Health Organization (WHO) Global TB Program released an overview of the key progress achieved so far regarding the implementation of the commitments made in the Moscow Declaration and the UN High-Level Meeting on TB.

Read More →

World Diabetes Day: Statements by WHO and The Union

The World Health Organization (WHO) and the International Union Against Tuberculosis and Lung Disease (The Union) released statements recognizing World Diabetes Day (November 14) and pressing for a more coordinated global approach to tackling the urgent co-epidemic of TB and diabetes.

Read More →

Meeting on update of the WHO drug-resistant TB treatment guidelines

The Guideline Development Group convened a meeting on 12-14 November 2019 on update of the World Health Organization (WHO) drug-resistant TB treatment guidelines.

Read More →

Roundup of WHO events around the 50th Union World Conference on Lung Health

The World Health Organization (WHO)'s Global TB Program released a newsletter presenting the WHO events around the 50th Union World Conference on Lung Health.

Read More →

WHO updates policy for the use of TB LAM test

The World Health Organization now recommends more broader use of urinary LAM assays for diagnosis of TB in people living with HIV.

Read More →

WHO updates policy for the use of lateral flow urine lipoarabinomannan assay (LF-LAM) for diagnosing active TB in people living with HIV

30 October 2019 | Geneva - The World Health Organization (WHO) has updated its guidance for the use of lateral flow urine lipoarabinomannan assay (LAM) in the diagnosis of tuberculosis (TB). Following new evidence, WHO now recommends a broader use of urinary LAM assays for diagnosis of TB in people living with HIV.

Read More →

WHO evaluation of centralized assays for detection of TB and of resistance to rifampicin and isoniazid

24 October 2019 | Geneva - The TB diagnostic pipeline has advanced significantly in the last decade, with promising tools being developed in recent years. Among the newest diagnostic tools emerging from the TB diagnostic pipeline are multi-disease high throughput centralized assays which permit upfront TB detection as well as the identification of isoniazid and rifampicin resistance. The World Health Organization convened a Technical Expert Group to assess the results of an external laboratory validation of four novel centralized TB assays: the Abbott RealTime MTB and MTB RIF/INH assays, the Roche cobas® MTB and MTB-RIF/INH assays, the Hain FluoroType® MTBDR assay, and the BD MAXTM MDR-TB assay.

Read More →

Global TB Report 2019

7 million people receive record levels of lifesaving TB treatment but 3 million still miss out. TB remains the top infectious killer in the world.

Read More →

Special mapping of existing TB training curricula and related materials

11 October 2019 | Geneva: TB care is a rapidly evolving field with regular updates to policies and guidelines based on newly emerging evidence. WHO and partners frequently receive requests from member states for training curricula to facilitate rapid adoption and adaptation of WHO guidance at country level. This is especially critical given the push for accelerating the TB response to reach the targets in the political declaration of the United Nations high-level meeting on TB by Heads of State in 2018. These are aligned with the End TB Strategy and TB related Sustainable Development Goals.

Read More →

Page 1 of 21 · Total posts: 10

1 2 Last→